- HOME
- Vol.64 No.3
- CLINICA NEUROL, 64: 181|184, 2024
- Vol.64 No.3 contents
Case Report
Cilostazol was effective for capsular warning syndrome during anticoagulant therapy: a case report
Ayane Kawatake, M.D., Hiroyuki Kawano, M.D., Ph.D., Yuko Honda, M.D., Ph.D., Yoshiko Unno, M.D., Ph.D. and Teruyuki Hirano, M.D., Ph.D.
Department of Stroke and Cerebrovascular Medicine, Kyorin University
An 88-year-old woman with atrial fibrillation was admitted to our hospital due to the right hemiplegia and aphasia. MRA shows the left middle cerebral artery M2 occlusion. After intravenous rt-PA, her symptoms improved. She was diagnosed with cardioembolic stroke, and was treated with direct oral anticoagulation therapy. However, she had repeated stereotypical transient right hemiparesis a week after index stroke. Her symptoms were considered capsular warning syndrome (CWS). After cilostazol was administered, no further transient neurological deteriorations occurred. CWS can coexist with acute cardioembolic stroke, and cilostazol was effective.
Full Text of this Article in PDF (1002K)
(CLINICA NEUROL, 64: 181|184, 2024)
key words: capsular warning syndrome, Cilostazol, antiplatelet therapy, cardio-embolic stroke
(Received: 23-Sep-23)